CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00365-07v1
14/12/1652    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Speare, D. J.
Right arrow Articles by Guselle, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Speare, D. J.
Right arrow Articles by Guselle, N. J.
Clinical and Vaccine Immunology, December 2007, p. 1652-1654, Vol. 14, No. 12
1071-412X/07/$08.00+0     doi:10.1128/CVI.00365-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Development of an Effective Whole-Spore Vaccine To Protect against Microsporidial Gill Disease in Rainbow Trout (Oncorhynchus mykiss) by Using a Low-Virulence Strain of Loma salmonae{triangledown}

D. J. Speare,* R. J. F. Markham, and N. J. Guselle

Department of Pathology and Microbiology, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada C1A 4P3

Received 5 September 2007/ Returned for modification 2 October 2007/ Accepted 7 October 2007

In determining the effective vaccine spore dose of a low-virulence strain of Loma salmonae to limit microsporidial gill disease in trout, we found that fish receiving 103 to 105 killed spores had the best protection against experimental infection, with 85% fewer xenomas in their gills than in the controls. Intraperitoneal delivery of the vaccine was effective, and the addition of adjuvant did not improve vaccine performance against this disease-causing microsporidian.


* Corresponding author. Mailing address: Atlantic Veterinary College, 550 University Avenue, Charlottetown, PEI, Canada C1A 4P3. Phone: (902) 566-0807. Fax: (902) 566-0851. E-mail: speare{at}upei.ca

{triangledown} Published ahead of print on 17 October 2007.


Clinical and Vaccine Immunology, December 2007, p. 1652-1654, Vol. 14, No. 12
1071-412X/07/$08.00+0     doi:10.1128/CVI.00365-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.